FindTrial
Sign In

Study on primary aldosteronism in Nanchang

Study on primary aldosteronism in Nanchang

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200057297
Enrollment
Unknown
Registered
2022-03-07
Start date
2018-01-01
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary aldosteronism

Interventions

None listed

Sponsors

The Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 16 years, males and females; 2. Hypertensive patients who have completed ARR screening and need for further assessment; 3. Patients who voluntarily signs an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients with severe heart disease, hepatic insufficiency, renal insufficiency; 2. Other types of secondary hypertension are suspected or confirmed, including Cushing's syndrome, pheochromocytoma, and renal artery stenosis; 3. Patients who the investigators believe do not meet the study criteria.

Design outcomes

Primary

MeasureTime frame
Clinical routine diagnosis and treatment data during the hospital;Out of hospital follow-up data;—

Countries

China

Contacts

Public ContactYifei Dong

The Second Affiliated Hospital of Nanchang University

yf_dong66@126.com+86 13576007061

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 11, 2026